{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:07:05Z","timestamp":1788934025435,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04688-3","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:42:37Z","timestamp":1788932557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone metastases in lung carcinoids: current challenges in diagnosis and treatment -A systematic review of an unexplored issue"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7458-3366","authenticated-orcid":false,"given":"Alice","family":"Laffi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5380-2141","authenticated-orcid":false,"given":"Andrea Gerardo Antonio","family":"Lania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6059-3982","authenticated-orcid":false,"given":"Anna","family":"Arecco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3733-2995","authenticated-orcid":false,"given":"Margherita","family":"Medici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7472-6598","authenticated-orcid":false,"given":"Francesco","family":"Ferra\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-3249","authenticated-orcid":false,"given":"Barbara","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antongiulio","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the NIKE group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"4688_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1053\/j.seminoncol.2018.07.001","volume":"45","author":"PE Sackstein","year":"2018","unstructured":"P.E. Sackstein, D.S. O\u2019Neil, A.I. Neugut, J. Chabot, T. Fojo, Epidemiologic trends in neuroendocrine tumors: An examination of incidence rates and survival of specific patient subgroups over the past 20 years. Semin Oncol. 45, 249\u2013258 (2018). https:\/\/doi.org\/10.1053\/j.seminoncol.2018.07.001","journal-title":"Semin Oncol."},{"key":"4688_CR2","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/annonc\/mdv041","volume":"26","author":"ME Caplin","year":"2015","unstructured":"M.E. Caplin, E. Baudin, P. Ferolla, P. Filosso, M. Garcia-Yuste, E. Lim, K. Oberg, G. Pelosi, A. Perren, R.E. Rossi, et al. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann. Oncol. 26, 1604\u20131620 (2015). https:\/\/doi.org\/10.1093\/annonc\/mdv041","journal-title":"Ann. Oncol."},{"key":"4688_CR3","doi-asserted-by":"publisher","first-page":"vii120","DOI":"10.1093\/annonc\/mds267","volume":"23","author":"K \u00d6berg","year":"2012","unstructured":"K. \u00d6berg, P. Hellman, P. Ferolla, M. Papotti, Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 23, vii120\u2013vii123 (2012). https:\/\/doi.org\/10.1093\/annonc\/mds267","journal-title":"Ann. Oncol."},{"key":"4688_CR4","volume-title":"Centre international de recherche sur le cancer eds: Thoracic tumours","author":"Organisation mondiale de la sant\u00e9","year":"2021","unstructured":"Organisation mondiale de la sant\u00e9, Centre international de recherche sur le cancer eds: Thoracic tumours (International agency for research on cancer, Lyon, 2021)"},{"key":"4688_CR5","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1002\/ijc.30400","volume":"139","author":"M Riihim\u00e4ki","year":"2016","unstructured":"M. Riihim\u00e4ki, A. Hemminki, K. Sundquist, J. Sundquist, K. Hemminki, The epidemiology of metastases in neuroendocrine tumors. Intl J. Cancer. 139, 2679\u20132686 (2016). https:\/\/doi.org\/10.1002\/ijc.30400","journal-title":"Intl J. Cancer"},{"key":"4688_CR6","doi-asserted-by":"publisher","first-page":"153303382110365","DOI":"10.1177\/15330338211036528","volume":"20","author":"J Zhang","year":"2021","unstructured":"J. Zhang, Q. Yu, Y. He, T. Hu, K. Chen, Z. Yang, X. Zhang, D. Cheng, Z. He, The Cancers-Specific Survival of Metastatic Pulmonary Carcinoids and Sites of Distant Metastasis: A Population-Based Study. Technol. Cancer Res. Treat. 20, 153303382110365 (2021). https:\/\/doi.org\/10.1177\/15330338211036528","journal-title":"Technol. Cancer Res. Treat."},{"key":"4688_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jtho.2019.02.002","volume":"14","author":"P Robelin","year":"2019","unstructured":"P. Robelin, J. Hadoux, J. Forestier, D. Planchard, V. Hervieu, A. Berdelou, J.-Y. Scoazec, P.-J. Valette, S. Leboulleux, M. Ducreux, C. Lombard-Bohas, E. Baudin, T. Walter, Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors. J. Thorac. Oncol. 14, 993\u20131002 (2019). https:\/\/doi.org\/10.1016\/j.jtho.2019.02.002","journal-title":"J. Thorac. Oncol."},{"issue":"16","key":"4688_CR8","doi-asserted-by":"publisher","first-page":"8957","DOI":"10.3390\/ijms25168957","volume":"17","author":"R Modica","year":"2024","unstructured":"R. Modica, E. Benevento, B. Altieri, R. Minotta, A. Liccardi, G. Cannavale, Di G. Iasi, A. Colao, Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis. Int. J. Mol. Sci. 17(16), 8957 (2024). https:\/\/doi.org\/10.3390\/ijms25168957","journal-title":"Int. J. Mol. Sci."},{"key":"4688_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1159\/000287255","volume":"91","author":"B Kos-Kud\u0142a","year":"2010","unstructured":"B. Kos-Kud\u0142a, D. O\u2019Toole, M. Falconi, D. Gross, G. Kl\u00f6ppel, A. Sundin, J. Ramage, K. \u00d6berg, B. Wiedenmann, P. Komminoth, Van E. Custem, M. Mallath, M. Papotti, M. Caplin, ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors. Neuroendocrinology. 91, 341\u2013350 (2010). https:\/\/doi.org\/10.1159\/000287255","journal-title":"Neuroendocrinology"},{"key":"4688_CR10","doi-asserted-by":"publisher","unstructured":"M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow, L. Shamseer, J.M. Tetzlaff, E.A. Akl, S.E. Brennan, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. n 71 (2021). https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"4688_CR11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s12020-019-01838-8","volume":"64","author":"KI Alexandraki","year":"2019","unstructured":"K.I. Alexandraki, M. Pizanias, I. Uri, D. Thomas, T. Page, D. Kolomodi, C.S. Low, O. Adesanya, M. Tsoli, D.J. Gross, H. Randeva, R. Srirajaskanthan, S. Grozinsky-Glasberg, G. Kaltsas, M.O. Weickert, The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice. Endocrine. 64, 690\u2013701 (2019). https:\/\/doi.org\/10.1007\/s12020-019-01838-8","journal-title":"Endocrine"},{"key":"4688_CR12","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0140-6736(61)92542-9","volume":"278","author":"M Sandler","year":"1961","unstructured":"M. Sandler, P.J. Scheuer, P.J. Watt, 5-hydroxytryptophan-secreting bronchial cacrinoid tumour. Lancet. 278, 1067\u20131070 (1961). https:\/\/doi.org\/10.1016\/S0140-6736(61)92542-9","journal-title":"Lancet"},{"key":"4688_CR13","doi-asserted-by":"publisher","first-page":"e210568","DOI":"10.1530\/EC-21-0568","volume":"11","author":"M Scopel","year":"2022","unstructured":"M. Scopel, De E. Carlo, F. Bergamo, S. Murgioni, R. Carandina, A.R. Cervino, M. Burei, F. Vianello, V. Zagonel, M. Fassan, et al. Bone metastases from neuroendocrine tumors: clinical and biological considerations. Endocr. Connections. 11, e210568 (2022). https:\/\/doi.org\/10.1530\/EC-21-0568","journal-title":"Endocr. Connections"},{"key":"4688_CR14","first-page":"709","volume":"83","author":"F Toomey","year":"1960","unstructured":"F. Toomey, B. Felson, Osteoblastic bone metastasis in gastrointestinal and bronchial carcinoids. Am. J. Roentgenol. Radium Ther. Nucl. Med. 83, 709\u2013715 (1960)","journal-title":"Am. J. Roentgenol. Radium Ther. Nucl. Med."},{"key":"4688_CR15","first-page":"1309","volume":"42","author":"T Traub","year":"2001","unstructured":"T. Traub, V. Petkov, S. Ofluoglu, T. Pangerl, M. Raderer, B.J. Fueger, W. Schima, A. Kurtaran, R. Dudczak, I. Virgolini, 111In-DOTA-Lanreotide Scintigraphy in Patients with Tumors of the Lung. J. Nucl. Med. 42, 1309\u20131315 (2001)","journal-title":"J. Nucl. Med."},{"key":"4688_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1440-1827.1990.tb01607.x","volume":"40","author":"Y Tsutsumi","year":"1990","unstructured":"Y. Tsutsumi, K. Yazaki, K. Yoshioka, Atypical Carcinoid Tumor of the Lung, Associated with Giant-cell Transformation in Bone Metastasis. Acta Pathol. Japonica. 40, 609\u2013615 (1990). https:\/\/doi.org\/10.1111\/j.1440-1827.1990.tb01607.x","journal-title":"Acta Pathol. Japonica"},{"key":"4688_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1634\/theoncologist.2017-0054","volume":"22","author":"VE Wang","year":"2017","unstructured":"V.E. Wang, L. Young, S. Ali, V.A. Miller, A. Urisman, J. Wolfe, T.G. Bivona, B. Damato, S. Fogh, E.K. Bergsland, A Case of Metastatic Atypical Neuroendocrine Tumor with ALK Translocation and Diffuse Brain Metastases. Oncologist. 22, 768\u2013773 (2017). https:\/\/doi.org\/10.1634\/theoncologist.2017-0054","journal-title":"Oncologist"},{"key":"4688_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/14017439009098055","volume":"24","author":"WH Warren","year":"1990","unstructured":"W.H. Warren, V.E. Gould, Long-Term Follow-Up of Classical Bronchial Carcinoid Tumors: Clinicopathologic Observations. Scand. J. Thorac. Cardiovasc. Surg. 24, 125\u2013130 (1990). https:\/\/doi.org\/10.3109\/14017439009098055","journal-title":"Scand. J. Thorac. Cardiovasc. Surg."},{"key":"4688_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2217\/lmt-2017-0010","volume":"6","author":"S Warsch","year":"2017","unstructured":"S. Warsch, M. Jahanzeb, Patient with typical carcinoid initially diagnosed as high-grade neuroendocrine carcinoma. Lung Cancer Manag. 6, 41\u201345 (2017). https:\/\/doi.org\/10.2217\/lmt-2017-0010","journal-title":"Lung Cancer Manag."},{"key":"4688_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2967\/jnumed.120.260760","volume":"63","author":"L Zidan","year":"2022","unstructured":"L. Zidan, A. Iravani, K. Oleinikov, S. Ben-Haim, D.J. Gross, A. Meirovitz, O. Maimon, T. Akhurst, M. Michael, R.J. Hicks, et al. Efficacy and Safety of 177 Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study. J. Nucl. Med. 63, 218\u2013225 (2022). https:\/\/doi.org\/10.2967\/jnumed.120.260760","journal-title":"J. Nucl. Med."},{"key":"4688_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/00006231-200208000-00006","volume":"23","author":"JM Zuetenhorst","year":"2002","unstructured":"J.M. Zuetenhorst, C.A. Hoefnageli, H. Boot, R.A. Vald\u00e9s Olmos, B.G. Taal, Evaluation of 111In-pentetreotide, 131I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease. Nucl. Med. Commun. 23, 735\u2013741 (2002). https:\/\/doi.org\/10.1097\/00006231-200208000-00006","journal-title":"Nucl. Med. Commun."},{"key":"4688_CR22","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1378\/chest.96.5.1206","volume":"96","author":"MB Allen","year":"1989","unstructured":"M.B. Allen, J. Shamash, K.M. Kerr, A.G. Leitch, Hypercalcemia in Atypical Bronchial Carcinoid Tumors. Chest. 96, 1206\u20131208 (1989). https:\/\/doi.org\/10.1378\/chest.96.5.1206","journal-title":"Chest"},{"key":"4688_CR23","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00259-008-0769-2","volume":"35","author":"V Ambrosini","year":"2008","unstructured":"V. Ambrosini, P. Tomassetti, P. Castellucci, D. Campana, G. Montini, D. Rubello, C. Nanni, A. Rizzello, R. Franchi, S. Fanti, Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. Eur. J. Nucl. Med. Mol. Imaging. 35, 1431\u20131438 (2008). https:\/\/doi.org\/10.1007\/s00259-008-0769-2","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4688_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1001\/jama.1960.63030040021021b","volume":"174","author":"WG Anlyan","year":"1960","unstructured":"W.G. Anlyan, Metastasizing Bronchial Adenoma: Occurrence in Patient with the Functioning Carcinoid Syndrome. JAMA 174, 415 (1960). https:\/\/doi.org\/10.1001\/jama.1960.63030040021021b","journal-title":"JAMA"},{"key":"4688_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/thx.32.4.509","volume":"32","author":"MH Ashraf","year":"1977","unstructured":"M.H. Ashraf, Bronchial carcinoid with osteoblastic metastases. Thorax. 32, 509\u2013511 (1977). https:\/\/doi.org\/10.1136\/thx.32.4.509","journal-title":"Thorax"},{"key":"4688_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00330-012-2615-y","volume":"23","author":"P Bhosale","year":"2013","unstructured":"P. Bhosale, A. Shah, W. Wei, G. Varadhachary, V. Johnson, V. Shah, V. Kundra, Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases. Eur. Radiol. 23, 400\u2013407 (2013). https:\/\/doi.org\/10.1007\/s00330-012-2615-y","journal-title":"Eur. Radiol."},{"key":"4688_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cllc.2016.11.004","volume":"18","author":"A Bongiovanni","year":"2017","unstructured":"A. Bongiovanni, F. Recine, N. Riva, F. Foca, C. Liverani, L. Mercatali, S. Nicolini, F. Pieri, D. Amadori, T. Ibrahim, Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of 18 FDG-PET\/CT. Clin. Lung Cancer. 18, 415\u2013420 (2017). https:\/\/doi.org\/10.1016\/j.cllc.2016.11.004","journal-title":"Clin. Lung Cancer"},{"key":"4688_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s42000-021-00316-z","volume":"21","author":"H Bostan","year":"2022","unstructured":"H. Bostan, H. Duger, P. Akhanli, M. Calapkulu, T.T. Turkmenoglu, A.K. Erdol, S.A. Duru, M.E. Sencar, M. Kizilgul, B. Ucan, et al. Cushing\u2019s syndrome due to adrenocorticotropic hormone-secreting metastatic neuroendocrine tumor of unknown primary origin: a case report and literature review. Hormones. 21, 147\u2013154 (2022). https:\/\/doi.org\/10.1007\/s42000-021-00316-z","journal-title":"Hormones"},{"key":"4688_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.lungcan.2014.08.012","volume":"86","author":"CR Chong","year":"2014","unstructured":"C.R. Chong, L.J. Wirth, M. Nishino, A.B. Chen, L.M. Sholl, M.H. Kulke, C.J. McNamee, P.A. J\u00e4nne, B.E. Johnson, Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors. Lung Cancer. 86, 241\u2013246 (2014). https:\/\/doi.org\/10.1016\/j.lungcan.2014.08.012","journal-title":"Lung Cancer"},{"key":"4688_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0046-8177(74)80026-2","volume":"5","author":"P Cookson","year":"1974","unstructured":"P. Cookson, Delayed osteoblastic metastasis from a childhood bronchial carcinoid tumor. Hum. Pathol. 5, 493\u2013496 (1974). https:\/\/doi.org\/10.1016\/S0046-8177(74)80026-2","journal-title":"Hum. Pathol."},{"key":"4688_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1477-7819-10-82","volume":"10","author":"RJD Cossetti","year":"2012","unstructured":"R.J.D. Cossetti, R.O.F. Bezerra, B. Gumz, A. Telles, F.P. Costa, Whole body diffusion for metastatic disease assessment in neuroendocrine carcinomas: comparison with OctreoScan\u00ae in two cases. World J. Surg. Onc. 10, 82 (2012). https:\/\/doi.org\/10.1186\/1477-7819-10-82","journal-title":"World J. Surg. Onc"},{"key":"4688_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/COC.0000000000000715","volume":"43","author":"S Dong","year":"2020","unstructured":"S. Dong, J. Liang, W. Zhai, Z. Yu, Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors. Am. J. Clin. Oncol. 43, 607\u2013614 (2020). https:\/\/doi.org\/10.1097\/COC.0000000000000715","journal-title":"Am. J. Clin. Oncol."},{"key":"4688_CR33","doi-asserted-by":"publisher","unstructured":"L. Duponchelle, E. Baudin, F. Subtil, C. Do Cao, E. Dansin, M. Perrier, M. Teissier, M. Haissaguerre, X. Cansouline, J. Hadoux, et al. Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors (GTE) and ENDOCAN\u2010RENATEN network. J. Neuroendocrinol. 35, e13331 (2023). https:\/\/doi.org\/10.1111\/jne.13331","DOI":"10.1111\/jne.13331"},{"key":"4688_CR34","first-page":"71","volume":"8","author":"J Feldman","year":"1977","unstructured":"J. Feldman, J. Plonk, 99mTc-pyrophosphate bone scans in patients with metastatic carcinoid tumors. J. Med. 8, 71\u201380 (1977)","journal-title":"J. Med."},{"key":"4688_CR35","first-page":"9","volume":"185","author":"R Garc\u00eda G\u00f3mez","year":"1989","unstructured":"R. Garc\u00eda G\u00f3mez, T. Fernandes, R. Jara S\u00e1nchez, C. Gonz\u00e1lez, R. Beca, G. P\u00e9rez Manga, Carcinoide bronquial. Tumor poco frecuente. Estudio cl\u00ednico de doce casos [Carcinoid tumor of the bronchi. An infrequent tumor. Clinical study of 12 cases]. Rev. Clin. Esp. 185, 9\u201313 (1989)","journal-title":"Rev. Clin. Esp."},{"key":"4688_CR36","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s00259-018-3945-z","volume":"45","author":"U Garske-Rom\u00e1n","year":"2018","unstructured":"U. Garske-Rom\u00e1n, M. Sandstr\u00f6m, K. Fr\u00f6ss Baron, L. Lundin, P. Hellman, S. Welin, S. Johansson, T. Khan, H. Lundqvist, B. Eriksson, et al. Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity. Eur. J. Nucl. Med. Mol. Imaging. 45, 970\u2013988 (2018). https:\/\/doi.org\/10.1007\/s00259-018-3945-z","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4688_CR37","doi-asserted-by":"publisher","unstructured":"D.A. Gococo-Benore, A. Boyle, N. Wylie, L. Drusbosky, A. Khoor, J.S. Starr, Cureus, (2022). https:\/\/doi.org\/10.7759\/cureus.22276","DOI":"10.7759\/cureus.22276"},{"key":"4688_CR38","first-page":"102","volume":"75","author":"M Greco","year":"1975","unstructured":"M. Greco, E. Waldo, Bronchial carcinoid tumors and bone metastases. N Y State J. Med. 75, 102\u2013105 (1975)","journal-title":"N Y State J. Med."},{"key":"4688_CR39","doi-asserted-by":"publisher","unstructured":"G.K. Guan, S. Rajoo, N. Mohd Dusa, N. Yahya, N.H.L. Bidin, Diabetes Insipidus Induced by Combination of Short-acting Ocreotide and Lanreotide for Recurrent Carcinoid Crisis of Neuroendocrine Tumour: A Case Report. JAFES. 36 (2021). https:\/\/doi.org\/10.15605\/jafes.036.02.09","DOI":"10.15605\/jafes.036.02.09"},{"key":"4688_CR40","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31104","author":"A Hayoune","year":"2022","unstructured":"A. Hayoune, B. Kharouaa, A. Thouil, H. Kouismi, Atypical Bronchial Carcinoid Tumor Revealed by Liver Biopsy. Cureus. (2022). https:\/\/doi.org\/10.7759\/cureus.31104","journal-title":"Cureus"},{"key":"4688_CR41","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1159\/000513249","volume":"111","author":"BCM Hermans","year":"2021","unstructured":"B.C.M. Hermans, De J. Vos-Geelen, J.L. Derks, L. Latten, I.H. Liem, Van Der J.M. Zwan, E.-J.M. Speel, M.W. Dercksen, A.-M.C. Dingemans, Unique Metastatic Patterns in Neuroendocrine Neoplasms of Different Primary Origin. Neuroendocrinology. 111, 1111\u20131120 (2021). https:\/\/doi.org\/10.1159\/000513249","journal-title":"Neuroendocrinology"},{"key":"4688_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.lungcan.2020.10.015","volume":"150","author":"BCM Hermans","year":"2020","unstructured":"B.C.M. Hermans, J.L. Derks, L. Moonen, C.H.J. Habraken, J.V. Der Th\u00fcsen, L.M. Hillen, E.J.M. Speel, A.-M.C. Dingemans, Pulmonary neuroendocrine neoplasms with well differentiated morphology and high proliferative activity: illustrated by a case series and review of the literature. Lung Cancer. 150, 152\u2013158 (2020). https:\/\/doi.org\/10.1016\/j.lungcan.2020.10.015","journal-title":"Lung Cancer"},{"key":"4688_CR43","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3892\/ol.2012.622","volume":"3","author":"T Hori","year":"2012","unstructured":"T. Hori, T. Yasuda, K. Suzuki, M. Kanamori, T. Kimura, Skeletal metastasis of carcinoid tumors: Two case reports and review of the literature. Oncol. Lett. 3, 1105\u20131108 (2012). https:\/\/doi.org\/10.3892\/ol.2012.622","journal-title":"Oncol. Lett."},{"key":"4688_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-2007-948311","volume":"115","author":"A Hubalewska-Dydejczyk","year":"2007","unstructured":"A. Hubalewska-Dydejczyk, K. Fr\u00f6ss-Baron, F. Go\u0142kowski, A. Sowa-Staszczak, R. Miko\u0142ajczak, B. Huszno, 99m Tc-EDDA\/HYNIC-Octreotate in Detection of Atypical Bronchial Carcinoid. Exp. Clin. Endocrinol. Diabetes. 115, 47\u201349 (2007). https:\/\/doi.org\/10.1055\/s-2007-948311","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"4688_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/archinte.1964.03860100123016","volume":"114","author":"G Hyman","year":"1964","unstructured":"G. Hyman, J. Wells, BRONCHIAL CARCINOID WITH OSTEOBLASTIC METASTASES. CASES WITH CARCINOID SYNDROME. Arch. Intern. Med. 114, 541\u2013546 (1964). https:\/\/doi.org\/10.1001\/archinte.1964.03860100123016","journal-title":"Arch. Intern. Med."},{"key":"4688_CR46","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2176\/nmc.46.609","volume":"46","author":"T Isaka","year":"2006","unstructured":"T. Isaka, M. Maruno, T. Suzuki, M. Sato, T. Yoshimine, Skull Metastases From Atypical Pulmonary Carcinoid Tumor in a 19-Year-Old Man-Case Report-: \u2014Case Report\u2014. Neurol. Med. Chir. (Tokyo). 46, 609\u2013613 (2006). https:\/\/doi.org\/10.2176\/nmc.46.609","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"4688_CR47","first-page":"15","volume":"63","author":"S Jacobsen","year":"1997","unstructured":"S. Jacobsen, S. Stephensen, B. Paaske, P. Lie, G. Lausten, Skeletal metastases of unknown origin: a retrospective analysis of 29 cases. Acta Orthop. Belg. 63, 15\u201322 (1997)","journal-title":"Acta Orthop. Belg."},{"key":"4688_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00361991","volume":"7","author":"D Johnson","year":"1982","unstructured":"D. Johnson, D. Osborne, E. Bossen, Case report 185: metastasis to the femur from a bronchial carcinoid tumor. Skeletal Radiol. 7, 293\u2013295 (1982)","journal-title":"Skeletal Radiol."},{"key":"4688_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/BF00348867","volume":"15","author":"P Kaplan","year":"1986","unstructured":"P. Kaplan, J. Phalen, R. Macke, Case report 372: Bronchial carcinoid metastatic to bone, specifically involving the left femur. Skeletal Radiol. 15, 383\u2013386 (1986). https:\/\/doi.org\/10.1007\/BF00348867","journal-title":"Skeletal Radiol."},{"key":"4688_CR50","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/MPA.0000000000000919","volume":"46","author":"BW Katona","year":"2017","unstructured":"B.W. Katona, G.A. Roccaro, M.C. Soulen, Y.-X. Yang, B.J. Bennett, B.P. Riff, R.A. Glynn, D. Wild, G.P. Nicolas, D.A. Pryma, et al. Efficacy of Peptide Receptor Radionuclide Therapy in a United States\u2013Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis. Pancreas. 46, 1121\u20131126 (2017). https:\/\/doi.org\/10.1097\/MPA.0000000000000919","journal-title":"Pancreas"},{"key":"4688_CR51","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MPA.0000000000000267","volume":"44","author":"J Kavecansky","year":"2015","unstructured":"J. Kavecansky, L. Wei, L. Caronia, M.-T. Ramirez, M. Bloomston, M.H. Shah, Bone Metastases in Well-to-Moderately Differentiated Neuroendocrine Tumors: A Single Institutional Review From the Ohio State University Medical Center. Pancreas. 44, 198\u2013203 (2015). https:\/\/doi.org\/10.1097\/MPA.0000000000000267","journal-title":"Pancreas"},{"key":"4688_CR52","first-page":"283","volume":"4","author":"D Kirkpatrick","year":"1975","unstructured":"D. Kirkpatrick, E. Dawson, C. Haskell, U. Batzdorf, Metastatic carcinoid presenting as a spinal tumor. Surg. Neurol. 4, 283\u2013287 (1975)","journal-title":"Surg. Neurol."},{"key":"4688_CR53","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.18632\/oncotarget.27659","volume":"11","author":"LE Lim","year":"2020","unstructured":"L.E. Lim, D.L. Chan, D. Thomas, Y. Du, G. Tincknell, A. Kuchel, A. Davis, D.L. Bailey, N. Pavlakis, G. Cehic, et al. Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours. Oncotarget. 11, 2636\u20132646 (2020). https:\/\/doi.org\/10.18632\/oncotarget.27659","journal-title":"Oncotarget"},{"key":"4688_CR54","first-page":"46","volume":"66","author":"F Merle-Vincent","year":"1999","unstructured":"F. Merle-Vincent, G. Chevrel, C. Lombard-Bohas, C. Felmann, P. Meunier, Bone metastases from bronchial carcinoid tumors. Two case-reports. Rev. Rhum Engl. Ed. 66, 46\u201348 (1999)","journal-title":"Rev. Rhum Engl. Ed."},{"key":"4688_CR55","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.lungcan.2020.10.005","volume":"150","author":"E Mirvis","year":"2020","unstructured":"E. Mirvis, C. Toumpanakis, D. Mandair, G. Gnanasegaran, M. Caplin, S. Navalkissoor, Efficacy and tolerability of peptide receptor radionuclide therapy (PRRT) in advanced metastatic bronchial neuroendocrine tumours (NETs). Lung Cancer. 150, 70\u201375 (2020). https:\/\/doi.org\/10.1016\/j.lungcan.2020.10.005","journal-title":"Lung Cancer"},{"key":"4688_CR56","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1007\/s00259-023-06166-8","volume":"50","author":"M Mitjavila","year":"2023","unstructured":"M. Mitjavila, P. Jimenez-Fonseca, P. Bell\u00f3, V. Pubul, J.C. Percovich, A. Garcia-Burillo, J. Hernando, J. Arbizu, E. Rode\u00f1o, M. Estorch, et al. Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study. Eur. J. Nucl. Med. Mol. Imaging. 50, 2486\u20132500 (2023). https:\/\/doi.org\/10.1007\/s00259-023-06166-8","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4688_CR57","doi-asserted-by":"publisher","unstructured":"H.J. Moersch, Bronchial adenoma. JAMA. 142, 299 (1950). https:\/\/doi.org\/10.1001\/jama.1950.02910230001001","DOI":"10.1001\/jama.1950.02910230001001"},{"key":"4688_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/01.rlu.0000196603.90748.a0","volume":"31","author":"BD Nguyen","year":"2006","unstructured":"B.D. Nguyen, P.C. Ram, Bronchopulmonary Carcinoid Tumor and Related Cervical Vertebral Metastasis With PET-Positive and Octreotide-Negative Scintigraphy. Clin. Nucl. Med. 31, 101\u2013103 (2006). https:\/\/doi.org\/10.1097\/01.rlu.0000196603.90748.a0","journal-title":"Clin. Nucl. Med."},{"key":"4688_CR59","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF00347385","volume":"7","author":"A Norman","year":"1981","unstructured":"A. Norman, A. Greenspan, G. Steiner, Case report 173: Verified osteolytic metastasis in the clavicle from a bronchial carcinoid tumor and probable osteoblastic metastasis in the humerus from the same lesion. Skeletal Radiol. 7, 155\u2013157 (1981). https:\/\/doi.org\/10.1007\/BF00347385","journal-title":"Skeletal Radiol."},{"key":"4688_CR60","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/RLU.0000000000001639","volume":"42","author":"RV Parghane","year":"2017","unstructured":"R.V. Parghane, S. Talole, K. Prabhash, S. Basu, Clinical Response Profile of Metastatic\/Advanced Pulmonary Neuroendocrine Tumors to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. Clin. Nucl. Med. 42, 428\u2013435 (2017). https:\/\/doi.org\/10.1097\/RLU.0000000000001639","journal-title":"Clin. Nucl. Med."},{"key":"4688_CR61","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.3346\/jkms.2023.38.e85","volume":"38","author":"HK Park","year":"2023","unstructured":"H.K. Park, G.Y. Kwon, Comparison of Metastatic Patterns Among Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Nonneuroendocrine Carcinomas of Various Primary Organs. J. Korean Med. Sci. 38, e85 (2023). https:\/\/doi.org\/10.3346\/jkms.2023.38.e85","journal-title":"J. Korean Med. Sci."},{"key":"4688_CR62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.remn.2009.08.003","volume":"29","author":"F P\u00e9rez \u00c1ngel","year":"2010","unstructured":"F. P\u00e9rez \u00c1ngel, J. S\u00e1nchez Catalicio, M. Salem, L. Castell\u00f3n S\u00e1nchez, M.I. Navarro, J.L. Fern\u00e1ndez, M.A. Claver Valderas, Gammagraf\u00eda \u00f3sea y gammagraf\u00eda con 111In-octre\u00f3tido en el diagn\u00f3stico de met\u00e1stasis \u00f3seas del tumor carcinoide bronquial. Revista Espa\u00f1ola de Med. Nuclear. 29, 38\u201339 (2010). https:\/\/doi.org\/10.1016\/j.remn.2009.08.003","journal-title":"Revista Espa\u00f1ola de Med. Nuclear"},{"key":"4688_CR63","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.21037\/jtd.2018.06.78","volume":"10","author":"M Peri","year":"2018","unstructured":"M. Peri, E. Botteri, E. Pisa, De F. Marinis, A. Ungaro, F. Spada, C.M. Grana, R. Gasparri, L. Spaggiari, N. Romentz, et al. A single-institution retrospective analysis of metachronous and synchronous metastatic bronchial neuroendocrine tumors. J. Thorac. Dis. 10, 3928\u20133939 (2018). https:\/\/doi.org\/10.21037\/jtd.2018.06.78","journal-title":"J. Thorac. Dis."},{"key":"4688_CR64","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0140-6736(62)90787-0","volume":"280","author":"A Pollard","year":"1962","unstructured":"A. Pollard, O. Fleming, R.G. Grainger, G. Meachim, an unusual case of metastatasing bronchial adenoma associated with the carcinoid syndrome. Lancet. 280, 1084\u20131086 (1962). https:\/\/doi.org\/10.1016\/S0140-6736(62)90787-0","journal-title":"Lancet"},{"key":"4688_CR65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.lungcan.2020.08.001","volume":"148","author":"M Rubino","year":"2020","unstructured":"M. Rubino, J.Y. Scoazec, E. Pisa, M. Faron, L. Spaggiari, J. Hadoux, F. Spada, D. Planchard, C.A. Cella, S. Leboulleux, et al. Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms. Lung Cancer. 148, 149\u2013158 (2020). https:\/\/doi.org\/10.1016\/j.lungcan.2020.08.001","journal-title":"Lung Cancer"},{"key":"4688_CR66","first-page":"74","volume":"7","author":"A Sabet","year":"2017","unstructured":"A. Sabet, A.R. Haug, C. Eiden, C.J. Auernhammer, B. Simon, P. Bartenstein, H.J. Biersack, S. Ezziddin, Efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis. Am. J. Nucl. Med. Mol. Imaging. 7, 74\u201383 (2017)","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"4688_CR67","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000457954","volume":"106","author":"M Scharf","year":"2018","unstructured":"M. Scharf, V. Petry, H. Daniel, A. Rinke, T.M. Gress, Bone Metastases in Patients with Neuroendocrine Neoplasm: Frequency and Clinical, Therapeutic, and Prognostic Relevance. Neuroendocrinology. 106, 30\u201337 (2018). https:\/\/doi.org\/10.1159\/000457954","journal-title":"Neuroendocrinology"},{"key":"4688_CR68","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.annonc.2021.01.003","volume":"32","author":"E Baudin","year":"2021","unstructured":"E. Baudin, M. Caplin, R. Garcia-Carbonero, N. Fazio, P. Ferolla, P.L. Filosso, A. Frilling, De W.W. Herder, D. H\u00f6rsch, U. Knigge, et al. Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 32, 439\u2013451 (2021). https:\/\/doi.org\/10.1016\/j.annonc.2021.01.003","journal-title":"Ann. Oncol."},{"key":"4688_CR69","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/cancers11091332","volume":"11","author":"B Altieri","year":"2019","unstructured":"B. Altieri, D.C. Dato, C. Martini, C. Sciammarella, D.A. Sarno, A. Colao, A. Faggiano, N.I.K.E. Group, Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management. Cancers (Basel). 11, 1332 (2019). https:\/\/doi.org\/10.3390\/cancers11091332","journal-title":"Cancers (Basel)"},{"key":"4688_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/15330338211036528","volume":"20","author":"J Zhang","year":"2021","unstructured":"J. Zhang, Q. Yu, Y. He, T. Hu, K. Chen, Z. Yang, X. Zhang, D. Cheng, Z. He, The Cancers-Specific Survival of Metastatic Pulmonary Carcinoids and Sites of Distant Metastasis: A Population-Based Study. Technol. Cancer Res. Treat. 20, 1\u20138 (2021). https:\/\/doi.org\/10.1177\/15330338211036528","journal-title":"Cancer Res. Treat."},{"issue":"9","key":"4688_CR71","doi-asserted-by":"publisher","first-page":"e250147","DOI":"10.1530\/ERC-25-0147","volume":"32","author":"E Lavezzi","year":"2025","unstructured":"E. Lavezzi, S. Jaafar, I. Chiardi, A. Brunetti, E. Morenghi, R.E. Rossi, M. Cellini, M.F. Birtolo, S. Uccella, A. Zerbi, et al. Clinical presentation of bone metastases in neuroendocrine tumors: a retrospective cohort study. Endocr. Relat. Cancer. 32(9), e250147 (2025)","journal-title":"Endocr. Relat. Cancer"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04688-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:42:40Z","timestamp":1788932560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04688-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4688"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04688-3","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"289"}}